These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
o
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
Virginia
|
52-1549373
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
incorporation or organization)
|
Identification No.)
|
|
|
|
|
4991 Lake Brook Drive, Suite 100, Glen Allen, Virginia
|
23060-9245
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
|
|
|
(804) 217-5800
(Registrant’s telephone number, including area code)
|
|
|
Large accelerated filer
|
o
|
Accelerated filer
|
x
|
|
Non-accelerated filer
|
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
o
|
|
|
|
|
Page
|
|
|
|||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
FINANCIAL INFORMATION
|
|
|
March 31, 2014
|
|
December 31, 2013
|
||||
|
ASSETS
|
(unaudited)
|
|
|
||||
|
Mortgage-backed securities (including pledged of $3,798,331 and
$3,873,584, respectively)
|
$
|
3,959,852
|
|
|
$
|
4,018,161
|
|
|
Mortgage loans held for investment, net
|
53,804
|
|
|
55,423
|
|
||
|
Cash and cash equivalents
|
61,168
|
|
|
69,330
|
|
||
|
Restricted cash
|
18,242
|
|
|
13,385
|
|
||
|
Derivative assets
|
12,064
|
|
|
18,488
|
|
||
|
Principal receivable on investments
|
8,112
|
|
|
12,999
|
|
||
|
Accrued interest receivable
|
23,387
|
|
|
21,703
|
|
||
|
Other assets, net
|
7,653
|
|
|
7,648
|
|
||
|
Total assets
|
$
|
4,144,282
|
|
|
$
|
4,217,137
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
||
|
Liabilities:
|
|
|
|
|
|
||
|
Repurchase agreements
|
$
|
3,485,544
|
|
|
$
|
3,580,754
|
|
|
Payable for unsettled mortgage-backed securities
|
16,086
|
|
|
10,358
|
|
||
|
Non-recourse collateralized financing
|
12,394
|
|
|
12,914
|
|
||
|
Derivative liabilities
|
11,137
|
|
|
6,681
|
|
||
|
Accrued interest payable
|
2,846
|
|
|
2,548
|
|
||
|
Accrued dividends payable
|
15,612
|
|
|
16,601
|
|
||
|
Other liabilities
|
1,648
|
|
|
1,405
|
|
||
|
Total liabilities
|
3,545,267
|
|
|
3,631,261
|
|
||
|
|
|
|
|
||||
|
Shareholders’ equity:
|
|
|
|
|
|
||
|
Preferred stock, par value $.01 per share, 8.5% Series A Cumulative Redeemable; 8,000,000 shares authorized; 2,300,000 shares issued and outstanding ($57,500 aggregate liquidation preference)
|
55,407
|
|
|
55,407
|
|
||
|
Preferred stock, par value $.01 per share, 7.625% Series B Cumulative Redeemable; 7,000,000 shares authorized; 2,250,000 shares issued and outstanding($56,250 aggregate liquidation preference)
|
54,251
|
|
|
54,251
|
|
||
|
Common stock, par value $.01 per share, 200,000,000 shares
authorized; 54,697,307 and 54,310,484 shares issued and outstanding, respectively
|
547
|
|
|
543
|
|
||
|
Additional paid-in capital
|
761,827
|
|
|
761,550
|
|
||
|
Accumulated other comprehensive loss
|
(4,256
|
)
|
|
(33,816
|
)
|
||
|
Accumulated deficit
|
(268,761
|
)
|
|
(252,059
|
)
|
||
|
Total shareholders' equity
|
599,015
|
|
|
585,876
|
|
||
|
Total liabilities and shareholders’ equity
|
$
|
4,144,282
|
|
|
$
|
4,217,137
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
Interest income:
|
|
|
|
||||
|
Mortgage-backed securities
|
$
|
26,902
|
|
|
$
|
32,039
|
|
|
Mortgage loans held for investment
|
738
|
|
|
943
|
|
||
|
|
27,640
|
|
|
32,982
|
|
||
|
Interest expense:
|
|
|
|
||||
|
Repurchase agreements
|
7,611
|
|
|
10,218
|
|
||
|
Non-recourse collateralized financing
|
22
|
|
|
238
|
|
||
|
|
7,633
|
|
|
10,456
|
|
||
|
|
|
|
|
||||
|
Net interest income
|
20,007
|
|
|
22,526
|
|
||
|
Provision for loan losses
|
—
|
|
|
(261
|
)
|
||
|
Loss on derivative instruments, net
|
(13,422
|
)
|
|
(17
|
)
|
||
|
(Loss) gain on sale of investments, net
|
(3,307
|
)
|
|
1,391
|
|
||
|
Fair value adjustments, net
|
32
|
|
|
(140
|
)
|
||
|
Other income (expense), net
|
75
|
|
|
(88
|
)
|
||
|
General and administrative expenses:
|
|
|
|
||||
|
Compensation and benefits
|
(2,552
|
)
|
|
(2,358
|
)
|
||
|
Other general and administrative
|
(1,567
|
)
|
|
(1,450
|
)
|
||
|
Net (loss) income
|
(734
|
)
|
|
19,603
|
|
||
|
Preferred stock dividends
|
(2,294
|
)
|
|
(1,222
|
)
|
||
|
Net (loss) income to common shareholders
|
$
|
(3,028
|
)
|
|
$
|
18,381
|
|
|
|
|
|
|
||||
|
Other comprehensive income:
|
|
|
|
||||
|
Change in fair value of available-for-sale investments
|
23,965
|
|
|
5,897
|
|
||
|
Reclassification adjustment for (loss) gain on sale of investments, net
|
3,307
|
|
|
(1,391
|
)
|
||
|
Change in fair value of cash flow hedges
|
—
|
|
|
437
|
|
||
|
Reclassification adjustment for cash flow hedges (including de-designated hedges)
|
2,288
|
|
|
4,103
|
|
||
|
Total other comprehensive income
|
29,560
|
|
|
9,046
|
|
||
|
Comprehensive income to common shareholders
|
$
|
26,532
|
|
|
$
|
27,427
|
|
|
|
|
|
|
||||
|
Weighted average common shares - basic and diluted
|
54,626
|
|
|
54,300
|
|
||
|
Net (loss) income per common share - basic and diluted
|
$
|
(0.06
|
)
|
|
$
|
0.34
|
|
|
|
Preferred
Stock
|
|
Common
Stock
|
|
Additional
Paid-in
Capital
|
|
Accumulated Other
Comprehensive Loss
|
|
Accumulated
Deficit
|
|
Total
|
||||||||||||
|
Balance as of
December 31, 2013
|
$
|
109,658
|
|
|
$
|
543
|
|
|
$
|
761,550
|
|
|
$
|
(33,816
|
)
|
|
$
|
(252,059
|
)
|
|
$
|
585,876
|
|
|
Stock issuance
|
—
|
|
|
1
|
|
|
143
|
|
|
—
|
|
|
—
|
|
|
144
|
|
||||||
|
Granting and vesting of restricted stock
|
—
|
|
|
4
|
|
|
668
|
|
|
—
|
|
|
—
|
|
|
672
|
|
||||||
|
Amortization of stock issuance costs
|
—
|
|
|
—
|
|
|
(30
|
)
|
|
—
|
|
|
—
|
|
|
(30
|
)
|
||||||
|
Adjustments for tax withholding on share-based compensation
|
—
|
|
|
(1
|
)
|
|
(504
|
)
|
|
—
|
|
|
—
|
|
|
(505
|
)
|
||||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(734
|
)
|
|
(734
|
)
|
||||||
|
Dividends on preferred stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,294
|
)
|
|
(2,294
|
)
|
||||||
|
Dividends on common stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(13,674
|
)
|
|
(13,674
|
)
|
||||||
|
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
29,560
|
|
|
—
|
|
|
29,560
|
|
||||||
|
Balance as of March 31, 2014
|
$
|
109,658
|
|
|
$
|
547
|
|
|
$
|
761,827
|
|
|
$
|
(4,256
|
)
|
|
$
|
(268,761
|
)
|
|
$
|
599,015
|
|
|
|
Preferred
Stock
|
|
Common
Stock
|
|
Additional
Paid-in
Capital
|
|
Accumulated Other
Comprehensive Income
|
|
Accumulated
Deficit
|
|
Total
|
||||||||||||
|
Balance as of
December 31, 2012
|
$
|
55,407
|
|
|
$
|
543
|
|
|
$
|
759,214
|
|
|
$
|
52,511
|
|
|
$
|
(250,965
|
)
|
|
$
|
616,710
|
|
|
Stock issuance
|
—
|
|
|
5
|
|
|
5,178
|
|
|
—
|
|
|
—
|
|
|
5,183
|
|
||||||
|
Granting and vesting of restricted stock
|
—
|
|
|
1
|
|
|
455
|
|
|
—
|
|
|
—
|
|
|
456
|
|
||||||
|
Amortization of stock issuance costs
|
—
|
|
|
—
|
|
|
(30
|
)
|
|
—
|
|
|
—
|
|
|
(30
|
)
|
||||||
|
Adjustments for tax withholding on share-based compensation
|
—
|
|
|
(1
|
)
|
|
(545
|
)
|
|
—
|
|
|
—
|
|
|
(546
|
)
|
||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
19,603
|
|
|
19,603
|
|
||||||
|
Dividends on preferred stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,222
|
)
|
|
(1,222
|
)
|
||||||
|
Dividends on common stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(15,902
|
)
|
|
(15,902
|
)
|
||||||
|
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
9,046
|
|
|
—
|
|
|
9,046
|
|
||||||
|
Balance as of March 31, 2013
|
$
|
55,407
|
|
|
$
|
548
|
|
|
$
|
764,272
|
|
|
$
|
61,557
|
|
|
$
|
(248,486
|
)
|
|
$
|
633,298
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
Operating activities:
|
|
|
|
||||
|
Net (loss) income
|
$
|
(734
|
)
|
|
$
|
19,603
|
|
|
Adjustments to reconcile net (loss) income to cash provided by operating activities:
|
|
|
|
|
|
||
|
Increase in accrued interest receivable
|
(1,684
|
)
|
|
(1,401
|
)
|
||
|
Increase (decrease) in accrued interest payable
|
298
|
|
|
(22
|
)
|
||
|
Provision for loan losses
|
—
|
|
|
261
|
|
||
|
Loss on derivative instruments, net
|
13,422
|
|
|
17
|
|
||
|
Loss (gain) on sale of investments, net
|
3,307
|
|
|
(1,391
|
)
|
||
|
Fair value adjustments, net
|
(32
|
)
|
|
140
|
|
||
|
Amortization and depreciation
|
34,829
|
|
|
32,117
|
|
||
|
Stock-based compensation expense
|
672
|
|
|
481
|
|
||
|
Other operating activities
|
(175
|
)
|
|
(4,400
|
)
|
||
|
Net cash and cash equivalents provided by operating activities
|
49,903
|
|
|
45,405
|
|
||
|
Investing activities:
|
|
|
|
|
|
||
|
Purchase of investments
|
(127,552
|
)
|
|
(438,376
|
)
|
||
|
Principal payments received on investments
|
128,676
|
|
|
215,751
|
|
||
|
Proceeds from sales of investments
|
59,799
|
|
|
31,158
|
|
||
|
Principal payments received on mortgage loans held for investment, net
|
1,605
|
|
|
5,737
|
|
||
|
Net payments on derivatives not designated as hedges
|
(2,542
|
)
|
|
(174
|
)
|
||
|
Other investing activities
|
(5
|
)
|
|
(827
|
)
|
||
|
Net cash and cash equivalents provided by (used in) investing activities
|
59,981
|
|
|
(186,731
|
)
|
||
|
Financing activities:
|
|
|
|
|
|
||
|
(Repayments of) borrowings under repurchase agreements, net
|
(95,314
|
)
|
|
144,023
|
|
||
|
Principal payments on non-recourse collateralized financing
|
(527
|
)
|
|
(2,024
|
)
|
||
|
Increase in restricted cash
|
(4,857
|
)
|
|
—
|
|
||
|
Proceeds from issuance of common stock, net of issuance costs
|
114
|
|
|
5,152
|
|
||
|
Payments related to tax withholding for share-based compensation
|
(505
|
)
|
|
(545
|
)
|
||
|
Dividends paid
|
(16,957
|
)
|
|
(16,960
|
)
|
||
|
Net cash and cash equivalents (used in) provided by financing activities
|
(118,046
|
)
|
|
129,646
|
|
||
|
|
|
|
|
||||
|
Net decrease in cash and cash equivalents
|
(8,162
|
)
|
|
(11,680
|
)
|
||
|
Cash and cash equivalents at beginning of period
|
69,330
|
|
|
55,809
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
61,168
|
|
|
$
|
44,129
|
|
|
Supplemental Disclosure of Cash Activity:
|
|
|
|
|
|
||
|
Cash paid for interest
|
$
|
4,935
|
|
|
$
|
10,381
|
|
|
|
For the Three Months Ended
|
||||||||||||||
|
|
March 31, 2014
|
|
March 31, 2013
|
||||||||||||
|
|
Net
Income
|
|
Weighted-Average Common Shares
|
|
Net
Income
|
|
Weighted-
Average
Common
Shares
|
||||||||
|
Net (loss) income
|
$
|
(734
|
)
|
|
|
|
$
|
19,603
|
|
|
|
||||
|
Preferred stock dividends
|
(2,294
|
)
|
|
|
|
(1,222
|
)
|
|
|
||||||
|
Net (loss) income to common shareholders
|
(3,028
|
)
|
|
54,625,601
|
|
|
18,381
|
|
|
54,300,020
|
|
||||
|
Effect of dilutive stock options
|
—
|
|
|
—
|
|
|
—
|
|
|
754
|
|
||||
|
Diluted net (loss) income to common shareholders
|
$
|
(3,028
|
)
|
|
54,625,601
|
|
|
$
|
18,381
|
|
|
54,300,774
|
|
||
|
Net (loss) income per common share:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
|
|
|
$
|
(0.06
|
)
|
|
|
|
|
$
|
0.34
|
|
||
|
Diluted
(1)
|
|
|
|
$
|
(0.06
|
)
|
|
|
|
|
$
|
0.34
|
|
||
|
|
March 31, 2014
|
|||||||||||||||||||||||||
|
|
Par
|
|
Net Premium (Discount)
|
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Fair Value
|
|
WAC
|
|||||||||||||
|
Agency:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
RMBS
|
$
|
2,438,133
|
|
|
$
|
139,899
|
|
|
$
|
2,578,032
|
|
|
$
|
6,708
|
|
|
$
|
(45,438
|
)
|
|
$
|
2,539,302
|
|
|
3.20
|
%
|
|
CMBS
|
286,931
|
|
|
19,838
|
|
|
306,769
|
|
|
11,384
|
|
|
(509
|
)
|
|
317,644
|
|
|
5.23
|
%
|
||||||
|
CMBS IO
(1)
|
—
|
|
|
461,523
|
|
|
461,523
|
|
|
11,581
|
|
|
(1,859
|
)
|
|
471,245
|
|
|
0.94
|
%
|
||||||
|
Total Agency AFS:
|
2,725,064
|
|
|
621,260
|
|
|
3,346,324
|
|
|
29,673
|
|
|
(47,806
|
)
|
|
3,328,191
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Non-Agency:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
RMBS
|
15,454
|
|
|
(7
|
)
|
|
15,447
|
|
|
209
|
|
|
(86
|
)
|
|
15,570
|
|
|
4.42
|
%
|
||||||
|
CMBS
|
375,209
|
|
|
(17,819
|
)
|
|
357,390
|
|
|
19,448
|
|
|
(842
|
)
|
|
375,996
|
|
|
5.05
|
%
|
||||||
|
CMBS IO
(1)
|
—
|
|
|
209,301
|
|
|
209,301
|
|
|
3,374
|
|
|
(1,148
|
)
|
|
211,527
|
|
|
0.80
|
%
|
||||||
|
Total non-Agency AFS:
|
390,663
|
|
|
191,475
|
|
|
582,138
|
|
|
23,031
|
|
|
(2,076
|
)
|
|
603,093
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Total AFS securities
|
$
|
3,115,727
|
|
|
$
|
812,735
|
|
|
$
|
3,928,462
|
|
|
$
|
52,704
|
|
|
$
|
(49,882
|
)
|
|
$
|
3,931,284
|
|
|
|
|
|
(1)
|
The notional balance for Agency CMBS IO and non-Agency CMBS IO was
$10,582,484
and
$5,053,884
, respectively, as of
March 31, 2014
.
|
|
|
December 31, 2013
|
|||||||||||||||||||||||||
|
|
Par
|
|
Net Premium (Discount)
|
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Fair Value
|
|
WAC
|
|||||||||||||
|
Agency:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
RMBS
|
$
|
2,591,568
|
|
|
$
|
154,220
|
|
|
$
|
2,745,788
|
|
|
$
|
6,104
|
|
|
$
|
(59,742
|
)
|
|
$
|
2,692,150
|
|
|
3.22
|
%
|
|
CMBS
|
273,830
|
|
|
19,061
|
|
|
292,891
|
|
|
10,793
|
|
|
(900
|
)
|
|
302,784
|
|
|
5.07
|
%
|
||||||
|
CMBS IO
(1)
|
—
|
|
|
453,766
|
|
|
453,766
|
|
|
9,895
|
|
|
(3,334
|
)
|
|
460,327
|
|
|
0.83
|
%
|
||||||
|
Total Agency AFS:
|
2,865,398
|
|
|
627,047
|
|
|
3,492,445
|
|
|
26,792
|
|
|
(63,976
|
)
|
|
3,455,261
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Non-Agency:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
RMBS
|
13,845
|
|
|
(338
|
)
|
|
13,507
|
|
|
338
|
|
|
(80
|
)
|
|
13,765
|
|
|
4.61
|
%
|
||||||
|
CMBS
|
375,703
|
|
|
(18,277
|
)
|
|
357,426
|
|
|
15,366
|
|
|
(3,511
|
)
|
|
369,281
|
|
|
5.10
|
%
|
||||||
|
CMBS IO
(1)
|
—
|
|
|
150,518
|
|
|
150,518
|
|
|
2,618
|
|
|
(1,999
|
)
|
|
151,137
|
|
|
0.66
|
%
|
||||||
|
Total non-Agency AFS:
|
389,548
|
|
|
131,903
|
|
|
521,451
|
|
|
18,322
|
|
|
(5,590
|
)
|
|
534,183
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Total AFS securities
|
$
|
3,254,946
|
|
|
$
|
758,950
|
|
|
$
|
4,013,896
|
|
|
$
|
45,114
|
|
|
$
|
(69,566
|
)
|
|
$
|
3,989,444
|
|
|
|
|
|
(1)
|
The notional balance for the Agency CMBS IO and non-Agency CMBS IO was
$10,160,502
and
$4,274,957
, respectively, as of
December 31, 2013
.
|
|
|
March 31, 2014
|
|
December 31, 2013
|
|||||||||||||||||
|
|
Fair Value
|
|
Gross Unrealized Losses
|
|
# of Securities
|
|
Fair Value
|
|
Gross Unrealized Losses
|
|
# of Securities
|
|||||||||
|
Continuous unrealized loss position for less than 12 months:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Agency MBS
|
$
|
1,563,078
|
|
|
$
|
(29,207
|
)
|
|
120
|
|
|
$
|
1,912,937
|
|
|
$
|
(43,543
|
)
|
|
150
|
|
Non-Agency MBS
|
126,578
|
|
|
(1,990
|
)
|
|
23
|
|
|
162,558
|
|
|
(5,435
|
)
|
|
39
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Continuous unrealized loss position for 12 months or longer:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Agency MBS
|
$
|
767,744
|
|
|
$
|
(18,600
|
)
|
|
80
|
|
|
$
|
670,402
|
|
|
$
|
(20,433
|
)
|
|
67
|
|
Non-Agency MBS
|
1,676
|
|
|
(86
|
)
|
|
5
|
|
|
6,310
|
|
|
(155
|
)
|
|
6
|
||||
|
|
|
March 31, 2014
|
|||||||||
|
Collateral Type
|
|
Balance
|
|
Weighted
Average Rate
|
|
Fair Value of
Collateral Pledged
|
|||||
|
Agency RMBS
|
|
$
|
2,350,781
|
|
|
0.39
|
%
|
|
2,421,202
|
|
|
|
Agency CMBS
|
|
265,475
|
|
|
0.37
|
%
|
|
330,182
|
|
||
|
Agency CMBS IOs
|
|
382,327
|
|
|
1.14
|
%
|
|
471,173
|
|
||
|
Non-Agency RMBS
|
|
11,905
|
|
|
1.77
|
%
|
|
14,691
|
|
||
|
Non-Agency CMBS
|
|
309,398
|
|
|
1.22
|
%
|
|
371,273
|
|
||
|
Non-Agency CMBS IO
|
|
149,105
|
|
|
1.23
|
%
|
|
187,227
|
|
||
|
Securitization financing bonds
|
|
16,692
|
|
|
1.52
|
%
|
|
18,607
|
|
||
|
Deferred costs
|
|
(139
|
)
|
|
n/a
|
|
|
n/a
|
|
||
|
|
|
$
|
3,485,544
|
|
|
0.59
|
%
|
|
$
|
3,814,355
|
|
|
|
|
December 31, 2013
|
|||||||||
|
Collateral Type
|
|
Balance
|
|
Weighted
Average Rate
|
|
Fair Value of Collateral Pledged
|
|||||
|
Agency RMBS
|
|
$
|
2,522,503
|
|
|
0.42
|
%
|
|
2,598,158
|
|
|
|
Agency CMBS
|
|
246,849
|
|
|
0.39
|
%
|
|
306,318
|
|
||
|
Agency CMBS IOs
|
|
369,948
|
|
|
1.16
|
%
|
|
449,072
|
|
||
|
Non-Agency RMBS
|
|
10,569
|
|
|
1.80
|
%
|
|
12,746
|
|
||
|
Non-Agency CMBS
|
|
303,674
|
|
|
1.27
|
%
|
|
367,859
|
|
||
|
Non-Agency CMBS IOs
|
|
106,803
|
|
|
1.27
|
%
|
|
136,227
|
|
||
|
Securitization financing bonds
|
|
20,651
|
|
|
1.59
|
%
|
|
19,686
|
|
||
|
Deferred costs
|
|
(243
|
)
|
|
n/a
|
|
|
n/a
|
|
||
|
|
|
$
|
3,580,754
|
|
|
0.61
|
%
|
|
$
|
3,890,066
|
|
|
Original Maturity
|
|
March 31,
2014 |
|
December 31,
2013 |
||||
|
30 days or less
|
|
$
|
369,542
|
|
|
$
|
206,112
|
|
|
31 to 60 days
|
|
715,516
|
|
|
492,145
|
|
||
|
61 to 90 days
|
|
987,579
|
|
|
665,020
|
|
||
|
91 to 120 days
|
|
545,628
|
|
|
783,371
|
|
||
|
121 to 190 days
|
|
867,418
|
|
|
1,434,349
|
|
||
|
|
|
$
|
3,485,683
|
|
|
$
|
3,580,997
|
|
|
|
|
|
|
|
|
March 31, 2014
|
|
December 31, 2013
|
||||||||||||
|
Type of Derivative Instrument
|
|
Accounting Designation
|
|
Balance Sheet Location:
|
|
Fair Value
|
|
Aggregate Notional Amount
|
|
Fair Value
|
|
Aggregate Notional Amount
|
||||||||
|
Interest rate swaps
|
|
Non-hedging
|
|
Derivative assets
|
|
$
|
12,064
|
|
|
$
|
525,000
|
|
|
$
|
18,488
|
|
|
$
|
575,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Interest rate swaps
|
|
Non-hedging
|
|
|
|
$
|
(1,378
|
)
|
|
$
|
325,000
|
|
|
$
|
(1,336
|
)
|
|
$
|
215,000
|
|
|
Eurodollar futures
|
|
Non-hedging
|
|
|
|
(9,759
|
)
|
|
9,000,000
|
|
|
(5,345
|
)
|
|
9,000,000
|
|
||||
|
|
|
|
|
Derivative liabilities
|
|
$
|
(11,137
|
)
|
|
$
|
9,325,000
|
|
|
$
|
(6,681
|
)
|
|
$
|
9,215,000
|
|
|
(amounts in thousands)
|
Interest Rate Swaps
|
|
Eurodollar Futures
|
||||
|
Notional amount as of December 31, 2013
|
$
|
790,000
|
|
|
$
|
9,000,000
|
|
|
Additions
|
75,000
|
|
|
—
|
|
||
|
Settlements, terminations, or expirations
|
(15,000
|
)
|
|
—
|
|
||
|
Notional amount as of March 31, 2014
(1)
|
$
|
850,000
|
|
|
$
|
9,000,000
|
|
|
(1)
|
The Eurodollar futures notional amount as of March 31, 2014 represents the total notional of the 3-month contracts with expiration dates from 2016 to 2020. The maximum notional outstanding for any future 3-month period does not exceed $1,175,000.
|
|
Remaining
Maturity
|
|
Notional Amount
|
|
Weighted-Average
Fixed Rate Swapped
|
|||
|
37-48 months
|
|
185,000
|
|
|
0.92
|
%
|
|
|
49-60 months
|
|
350,000
|
|
|
1.62
|
%
|
|
|
61-72 months
|
|
35,000
|
|
|
1.24
|
%
|
|
|
73-84 months
|
|
100,000
|
|
|
2.08
|
%
|
|
|
85-108 months
|
|
—
|
|
|
—
|
%
|
|
|
109-127 months
|
|
180,000
|
|
|
2.13
|
%
|
|
|
|
|
$
|
850,000
|
|
|
1.61
|
%
|
|
|
|
Three Months Ended
|
||||||
|
|
|
March 31,
|
||||||
|
Type of Derivative Instrument
|
|
2014
|
|
2013
|
||||
|
Interest rate swaps
|
|
$
|
(9,008
|
)
|
|
$
|
(17
|
)
|
|
Eurodollar futures
|
|
(4,414
|
)
|
|
—
|
|
||
|
Loss on derivative instruments, net
|
|
$
|
(13,422
|
)
|
|
$
|
(17
|
)
|
|
|
Offsetting of Assets
|
||||||||||||||||||||||
|
|
Gross Amount of Recognized Assets
|
|
Gross Amount Offset in the Balance Sheet
|
|
Net Amount of Assets Presented in the Balance Sheet
|
|
Gross Amount Not Offset in the Balance Sheet
|
|
Net Amount
|
||||||||||||||
|
Financial Instruments Received as Collateral
|
|
Cash Received as Collateral
|
|||||||||||||||||||||
|
March 31, 2014
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Derivative assets
|
$
|
12,064
|
|
|
$
|
—
|
|
|
$
|
12,064
|
|
|
$
|
(395
|
)
|
|
$
|
(7,954
|
)
|
|
$
|
3,715
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
December 31, 2013:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Derivative assets
|
$
|
18,488
|
|
|
$
|
—
|
|
|
$
|
18,488
|
|
|
$
|
(193
|
)
|
|
$
|
(12,141
|
)
|
|
$
|
6,154
|
|
|
|
Offsetting of Liabilities
|
||||||||||||||||||||||
|
|
Gross Amount of Recognized Liabilities
|
|
Gross Amount Offset in the Balance Sheet
|
|
Net Amount of Liabilities Presented in the Balance Sheet
|
|
Gross Amount Not Offset in the Balance Sheet
|
|
Net Amount
|
||||||||||||||
|
Financial Instruments Posted as Collateral
|
|
Cash Posted as Collateral
|
|||||||||||||||||||||
|
March 31, 2014
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Derivative liabilities
|
$
|
11,137
|
|
|
$
|
—
|
|
|
$
|
11,137
|
|
|
$
|
(1,340
|
)
|
|
$
|
(9,797
|
)
|
|
$
|
—
|
|
|
Repurchase agreements
|
3,485,544
|
|
|
—
|
|
|
3,485,544
|
|
|
(3,485,544
|
)
|
|
—
|
|
|
—
|
|
||||||
|
|
$
|
3,496,681
|
|
|
$
|
—
|
|
|
$
|
3,496,681
|
|
|
$
|
(3,486,884
|
)
|
|
$
|
(9,797
|
)
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
December 31, 2013:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Derivative liabilities
|
$
|
6,681
|
|
|
$
|
—
|
|
|
$
|
6,681
|
|
|
$
|
(1,299
|
)
|
|
$
|
(5,382
|
)
|
|
$
|
—
|
|
|
Repurchase agreements
|
3,580,754
|
|
|
—
|
|
|
3,580,754
|
|
|
(3,580,754
|
)
|
|
—
|
|
|
—
|
|
||||||
|
|
$
|
3,587,435
|
|
|
$
|
—
|
|
|
$
|
3,587,435
|
|
|
$
|
(3,582,053
|
)
|
|
$
|
(5,382
|
)
|
|
$
|
—
|
|
|
(1)
|
Amount disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the asset or liability presented in the balance sheet. The fair value of the actual collateral received by or posted to the same counterparty may exceed the amounts presented.
|
|
•
|
Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date. The fair value measurement of the Company's Eurodollar futures contracts are included in this category.
|
|
•
|
Level 2 – Inputs include quoted prices in active markets for similar assets or liabilities; quoted prices in inactive markets for identical or similar assets or liabilities; or inputs either directly observable or indirectly observable through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life. The Company’s assets and liabilities measured at fair value that are generally included in this category are Agency MBS, certain non-Agency MBS, and interest rate swaps.
|
|
•
|
Level 3 – Unobservable inputs are supported by little or no market activity. The unobservable inputs represent management’s best estimate of how market participants would price the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. The Company’s assets and liabilities measured at fair value that are generally included in this category are certain non-Agency MBS.
|
|
|
March 31, 2014
|
||||||||||||||
|
|
Fair Value
|
|
Level 1 - Unadjusted Quoted Prices in Active Markets
|
|
Level 2 - Observable Inputs
|
|
Level 3 - Unobservable Inputs
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Mortgage-backed securities
|
$
|
3,959,852
|
|
|
$
|
—
|
|
|
$
|
3,893,465
|
|
|
$
|
66,387
|
|
|
Derivative assets
|
12,064
|
|
|
—
|
|
|
12,064
|
|
|
—
|
|
||||
|
Total assets carried at fair value
|
$
|
3,971,916
|
|
|
$
|
—
|
|
|
$
|
3,905,529
|
|
|
$
|
66,387
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Derivative liabilities
|
$
|
11,137
|
|
|
$
|
9,759
|
|
|
$
|
1,378
|
|
|
$
|
—
|
|
|
Total liabilities carried at fair value
|
$
|
11,137
|
|
|
$
|
9,759
|
|
|
$
|
1,378
|
|
|
$
|
—
|
|
|
|
December 31, 2013
|
||||||||||||||
|
|
Fair Value
|
|
Level 1 - Unadjusted Quoted Prices in Active Markets
|
|
Level 2 - Observable Inputs
|
|
Level 3 - Unobservable Inputs
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Mortgage-backed securities
|
$
|
4,018,161
|
|
|
$
|
—
|
|
|
$
|
3,944,681
|
|
|
$
|
73,480
|
|
|
Derivative assets
|
18,488
|
|
|
—
|
|
|
18,488
|
|
|
—
|
|
||||
|
Total assets carried at fair value
|
$
|
4,036,649
|
|
|
$
|
—
|
|
|
$
|
3,963,169
|
|
|
$
|
73,480
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Derivative liabilities
|
$
|
6,681
|
|
|
$
|
5,345
|
|
|
$
|
1,336
|
|
|
$
|
—
|
|
|
Total liabilities carried at fair value
|
$
|
6,681
|
|
|
$
|
5,345
|
|
|
$
|
1,336
|
|
|
$
|
—
|
|
|
|
Quantitative Information about Level 3 Fair Value Measurements
(1)
|
|||||||||
|
|
Prepayment Speed
|
|
Default Rate
|
|
Severity
|
|
Discount Rate
|
|||
|
Non-Agency CMBS
|
20 CPY
|
|
2.5
|
%
|
|
35.0
|
%
|
|
8.8
|
%
|
|
Non-Agency RMBS
|
10 CPR
|
|
1.0
|
%
|
|
20.0
|
%
|
|
6.8
|
%
|
|
(1)
|
Data presented are weighted averages.
|
|
|
Three Months
|
||||||||||
|
|
March 31, 2014
|
||||||||||
|
|
Level 3 Fair Values
|
||||||||||
|
|
Non-Agency CMBS
|
|
Non-Agency RMBS
|
|
Total assets
|
||||||
|
Balance as of December 31, 2013
|
$
|
70,733
|
|
|
$
|
2,747
|
|
|
$
|
73,480
|
|
|
Change in fair value included in OCI
|
27
|
|
|
(126
|
)
|
|
(99
|
)
|
|||
|
Principal payments
|
(6,993
|
)
|
|
(395
|
)
|
|
(7,388
|
)
|
|||
|
Accretion
|
65
|
|
|
329
|
|
|
394
|
|
|||
|
Balance as of March 31, 2014
|
$
|
63,832
|
|
|
$
|
2,555
|
|
|
$
|
66,387
|
|
|
|
March 31, 2014
|
|
December 31, 2013
|
||||||||||||
|
|
Recorded Basis
|
|
Fair Value
|
|
Recorded Basis
|
|
Fair Value
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Mortgage-backed securities
|
$
|
3,959,852
|
|
|
$
|
3,959,852
|
|
|
$
|
4,018,161
|
|
|
$
|
4,018,161
|
|
|
Mortgage loans held for investment, net
(1)
|
53,804
|
|
|
45,188
|
|
|
55,423
|
|
|
46,383
|
|
||||
|
Derivative assets
|
12,064
|
|
|
12,064
|
|
|
18,488
|
|
|
18,488
|
|
||||
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Repurchase agreements
(2)
|
$
|
3,485,544
|
|
|
$
|
3,485,683
|
|
|
$
|
3,580,754
|
|
|
$
|
3,580,997
|
|
|
Non-recourse collateralized financing
(1)
|
12,394
|
|
|
11,915
|
|
|
12,914
|
|
|
12,414
|
|
||||
|
Derivative liabilities
|
11,137
|
|
|
11,137
|
|
|
6,681
|
|
|
6,681
|
|
||||
|
|
Three Months Ended
|
||||
|
|
March 31,
|
||||
|
|
2014
|
|
2013
|
||
|
Balance as of beginning of period
|
54,310,484
|
|
|
54,268,915
|
|
|
Common stock issued under DRIP
|
3,938
|
|
|
298,304
|
|
|
Common stock issued under ATM program
|
—
|
|
|
180,986
|
|
|
Common stock issued or redeemed under stock and incentive plans
|
442,035
|
|
|
139,600
|
|
|
Common stock forfeited for tax withholding on share-based compensation
|
(59,150
|
)
|
|
(52,385
|
)
|
|
Balance as of end of period
|
54,697,307
|
|
|
54,835,420
|
|
|
|
Three Months Ended
|
||||
|
|
March 31,
|
||||
|
|
2014
|
|
2013
|
||
|
Restricted stock outstanding as of beginning of period
|
520,969
|
|
|
448,283
|
|
|
Restricted stock granted
|
428,363
|
|
|
139,600
|
|
|
Restricted stock vested
|
(188,620
|
)
|
|
(153,720
|
)
|
|
Restricted stock outstanding as of end of period
|
760,712
|
|
|
434,163
|
|
|
|
Three Months Ended
|
||||||||
|
|
March 31, 2014
|
|
December 31, 2013
|
|
September 30, 2013
|
|
June 30, 2013
|
|
March 31, 2013
|
|
Average annualized effective yield:
|
|
|
|
|
|
|
|
|
|
|
RMBS
|
1.87%
|
|
1.85%
|
|
1.99%
|
|
1.91%
|
|
2.05%
|
|
CMBS
|
4.61%
|
|
4.65%
|
|
4.78%
|
|
4.75%
|
|
4.73%
|
|
CMBS IO
|
4.21%
|
|
4.47%
|
|
4.41%
|
|
4.53%
|
|
4.61%
|
|
All other investments
|
5.17%
|
|
5.26%
|
|
5.36%
|
|
5.44%
|
|
5.36%
|
|
Total average annualized effective yield
|
2.74%
|
|
2.72%
|
|
2.82%
|
|
2.86%
|
|
3.04%
|
|
Costs of financing
|
(0.87)%
|
|
(0.90)%
|
|
(0.88)%
|
|
(1.11)%
|
|
(1.15)%
|
|
Net interest spread
|
1.87%
|
|
1.82%
|
|
1.94%
|
|
1.75%
|
|
1.89%
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective borrowing cost
(1)
|
(0.86)%
|
|
(0.95)%
|
|
(1.17)%
|
|
(1.14)%
|
|
(1.17)%
|
|
Adjusted net interest spread
(1)
|
1.88%
|
|
1.77%
|
|
1.65%
|
|
1.72%
|
|
1.87%
|
|
(amounts in basis points)
|
March 31, 2014
|
|
December 31, 2013
|
|
September 30, 2013
|
|
June 30, 2013
|
||||||||||||
|
Hybrid ARM 5/1 (2.0% coupon) spread to Treasuries
|
|
21
|
|
|
|
|
30
|
|
|
|
|
40
|
|
|
|
|
45
|
|
|
|
Hybrid ARM 10/1 (2.5% coupon) spread to Treasuries
|
|
57
|
|
|
|
|
76
|
|
|
|
|
80
|
|
|
|
|
75
|
|
|
|
Agency CMBS spread to interest rate swaps
|
|
50
|
|
|
|
|
58
|
|
|
|
|
72
|
|
|
|
|
92
|
|
|
|
'A'-rated CMBS spread to interest rate swaps
|
|
190
|
|
|
|
|
220
|
|
|
|
|
255
|
|
|
|
|
287
|
|
|
|
Agency CMBS IO spread to Treasuries
|
|
155
|
|
|
|
|
165
|
|
|
|
|
200
|
|
|
|
|
200
|
|
|
|
|
March 31, 2014
|
|
December 31, 2013
|
|
September 30, 2013
|
|
June 30, 2013
|
|
March 31, 2013
|
|
Agency MBS
|
83.6%
|
|
85.5%
|
|
86.3%
|
|
85.9%
|
|
84.9%
|
|
Non-Agency MBS
|
15.0%
|
|
13.1%
|
|
12.3%
|
|
12.6%
|
|
13.6%
|
|
Other investments
|
1.4%
|
|
1.4%
|
|
1.5%
|
|
1.5%
|
|
1.5%
|
|
|
March 31, 2014
|
|
December 31, 2013
|
|
September 30, 2013
|
|
June 30, 2013
|
|
March 31, 2013
|
|
RMBS
|
64.5%
|
|
67.3%
|
|
68.5%
|
|
67.9%
|
|
65.0%
|
|
CMBS
|
18.5%
|
|
17.7%
|
|
17.2%
|
|
17.4%
|
|
19.3%
|
|
CMBS IO
|
17.0%
|
|
15.0%
|
|
14.3%
|
|
14.7%
|
|
15.7%
|
|
($ in thousands)
|
RMBS
|
|
CMBS
|
|
CMBS IO
(1)
|
|
Total
|
||||||||
|
Balance as of January 1, 2014
|
$
|
2,692,150
|
|
|
$
|
331,501
|
|
|
$
|
460,327
|
|
|
$
|
3,483,978
|
|
|
Purchases
|
10,247
|
|
|
16,171
|
|
|
25,389
|
|
|
51,807
|
|
||||
|
Principal payments
|
(113,207
|
)
|
|
(1,399
|
)
|
|
—
|
|
|
(114,606
|
)
|
||||
|
Sales
|
(56,801
|
)
|
|
—
|
|
|
(326
|
)
|
|
(57,127
|
)
|
||||
|
Change in net unrealized gain
|
14,908
|
|
|
966
|
|
|
3,160
|
|
|
19,034
|
|
||||
|
Net premium amortization
|
(7,995
|
)
|
|
(1,027
|
)
|
|
(17,305
|
)
|
|
(26,327
|
)
|
||||
|
Balance as of March 31, 2014
|
$
|
2,539,302
|
|
|
$
|
346,212
|
|
|
$
|
471,245
|
|
|
$
|
3,356,759
|
|
|
|
March 31, 2014
|
|
December 31, 2013
|
||||||||||||||||
|
($ in thousands)
|
Par Value
|
|
Reset Margin
|
|
WAC
|
|
Par Value
|
|
Reset Margin
|
|
WAC
|
||||||||
|
0-12 MTR
|
$
|
549,224
|
|
|
1.77
|
%
|
|
3.02
|
%
|
|
$
|
575,763
|
|
|
1.79
|
%
|
|
2.97
|
%
|
|
13-36 MTR
|
221,399
|
|
|
1.87
|
%
|
|
3.98
|
%
|
|
276,862
|
|
|
1.84
|
%
|
|
3.89
|
%
|
||
|
37-60 MTR
|
709,381
|
|
|
1.80
|
%
|
|
3.38
|
%
|
|
619,887
|
|
|
1.79
|
%
|
|
3.57
|
%
|
||
|
61-84 MTR
|
94,345
|
|
|
1.81
|
%
|
|
3.74
|
%
|
|
171,839
|
|
|
1.80
|
%
|
|
3.01
|
%
|
||
|
85-120 MTR
|
845,500
|
|
|
1.73
|
%
|
|
2.92
|
%
|
|
928,580
|
|
|
1.74
|
%
|
|
2.99
|
%
|
||
|
ARMs and Hybrid ARMs
|
2,419,849
|
|
|
1.78
|
%
|
|
3.21
|
%
|
|
2,572,931
|
|
|
1.78
|
%
|
|
3.22
|
%
|
||
|
Fixed
|
18,284
|
|
|
|
|
2.51
|
%
|
|
$
|
18,637
|
|
|
|
|
2.51
|
%
|
|||
|
Total
|
$
|
2,438,133
|
|
|
|
|
3.20
|
%
|
|
$
|
2,591,568
|
|
|
|
|
3.22
|
%
|
||
|
|
Three Months Ended
|
|||||||||||||
|
|
March 31, 2014
|
|
December 31, 2013
|
|
September 30, 2013
|
|
June 30, 2013
|
|
March 31, 2013
|
|||||
|
Agency RMBS
|
12.7
|
%
|
|
14.3
|
%
|
|
23.8
|
%
|
|
25.7
|
%
|
|
24.8
|
%
|
|
($ in thousands)
|
RMBS
|
|
CMBS
|
|
CMBS IO
(1)
|
|
Total
|
||||||||
|
Balance as of January 1, 2014
|
$
|
13,765
|
|
|
$
|
369,281
|
|
|
$
|
151,137
|
|
|
$
|
534,183
|
|
|
Purchases
|
3,500
|
|
|
12,895
|
|
|
65,076
|
|
|
81,471
|
|
||||
|
Principal payments
|
(1,891
|
)
|
|
(7,265
|
)
|
|
—
|
|
|
(9,156
|
)
|
||||
|
Sales
|
—
|
|
|
(5,978
|
)
|
|
—
|
|
|
(5,978
|
)
|
||||
|
Change in net unrealized gain
|
(135
|
)
|
|
6,751
|
|
|
1,607
|
|
|
8,223
|
|
||||
|
Net accretion (amortization)
|
331
|
|
|
311
|
|
|
(6,293
|
)
|
|
(5,651
|
)
|
||||
|
Balance as of March 31, 2014
|
$
|
15,570
|
|
|
$
|
375,995
|
|
|
$
|
211,527
|
|
|
$
|
603,092
|
|
|
|
|
Three Months Ended
|
||||||
|
|
|
March 31, 2014
|
||||||
|
Credit Rating At Purchase
|
|
Purchase Price
|
|
Premium (Discount)
|
||||
|
($ in thousands)
|
|
|
|
|
||||
|
Non-Agency CMBS IO rated AAA
(1)
|
|
$
|
65,076
|
|
|
$
|
65,076
|
|
|
Non-Agency CMBS rated A or BBB
|
|
12,895
|
|
|
(375
|
)
|
||
|
Non-Agency RMBS non-investment grade
|
|
3,500
|
|
|
—
|
|
||
|
Total purchases
|
|
$
|
81,471
|
|
|
$
|
64,701
|
|
|
|
March 31, 2014
|
||||||||||||||||||||||
|
|
Non-Agency CMBS
|
|
Non-Agency CMBS IO
|
||||||||||||||||||||
|
($ in thousands)
|
Fair Value
|
|
Net Unrealized Gain (Loss)
|
|
Related Borrowings
|
|
Fair Value
|
|
Net Unrealized Gain
|
|
Related Borrowings
|
||||||||||||
|
AAA
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
210,184
|
|
|
$
|
2,168
|
|
|
$
|
149,089
|
|
|
AA
|
75,990
|
|
|
2,091
|
|
|
69,983
|
|
|
1,343
|
|
|
58
|
|
|
16
|
|
||||||
|
A
|
251,959
|
|
|
16,161
|
|
|
204,961
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Below A/Not Rated
|
48,047
|
|
|
354
|
|
|
34,454
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
|
$
|
375,996
|
|
|
$
|
18,606
|
|
|
$
|
309,398
|
|
|
$
|
211,527
|
|
|
$
|
2,226
|
|
|
$
|
149,105
|
|
|
|
December 31, 2013
|
||||||||||||||||||||||
|
|
Non-Agency CMBS
|
|
Non-Agency CMBS IO
|
||||||||||||||||||||
|
($ in thousands)
|
Fair Value
|
|
Net Unrealized Gain
|
|
Related Borrowings
|
|
Fair Value
|
|
Net Unrealized Gain
|
|
Related Borrowings
|
||||||||||||
|
AAA
|
$
|
40,379
|
|
|
$
|
2,126
|
|
|
$
|
35,637
|
|
|
$
|
149,692
|
|
|
$
|
555
|
|
|
$
|
106,787
|
|
|
AA
|
40,022
|
|
|
62
|
|
|
35,402
|
|
|
1,445
|
|
|
65
|
|
|
16
|
|
||||||
|
A
|
237,261
|
|
|
10,307
|
|
|
194,952
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Below A/Not Rated
|
51,619
|
|
|
(641
|
)
|
|
37,683
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
|
$
|
369,281
|
|
|
$
|
11,854
|
|
|
$
|
303,674
|
|
|
$
|
151,137
|
|
|
$
|
620
|
|
|
$
|
106,803
|
|
|
|
March 31, 2014
|
|
December 31, 2013
|
||||||||||
|
($ in thousands)
|
Market Value of Collateral
|
|
Percentage
|
|
Market Value of Collateral
|
|
Percentage
|
||||||
|
Florida
|
$
|
78,271
|
|
|
13.1
|
%
|
|
$
|
82,269
|
|
|
13.9
|
%
|
|
California
|
74,785
|
|
|
12.5
|
%
|
|
81,353
|
|
|
13.7
|
%
|
||
|
Texas
|
63,821
|
|
|
10.7
|
%
|
|
69,044
|
|
|
11.6
|
%
|
||
|
New York
|
37,833
|
|
|
6.3
|
%
|
|
32,240
|
|
|
5.4
|
%
|
||
|
Virginia
|
29,235
|
|
|
4.9
|
%
|
|
30,784
|
|
|
5.2
|
%
|
||
|
Remaining states (not exceeding 4.7% individually)
|
312,347
|
|
|
52.5
|
%
|
|
297,398
|
|
|
50.2
|
%
|
||
|
|
$
|
596,292
|
|
|
100.0
|
%
|
|
$
|
593,088
|
|
|
100.0
|
%
|
|
($ in thousands)
|
Interest Rate Swaps
|
|
Eurodollar Futures
|
|
Total
|
|
Weighted-Average
Rate
(1)
|
|||||||
|
Effective 2014
|
$
|
800,245
|
|
|
$
|
—
|
|
|
$
|
800,245
|
|
|
1.58
|
%
|
|
Effective 2015
|
850,000
|
|
|
—
|
|
|
850,000
|
|
|
1.61
|
%
|
|||
|
Effective 2016
|
850,000
|
|
|
394,393
|
|
|
1,244,393
|
|
|
1.88
|
%
|
|||
|
Effective 2017
|
738,887
|
|
|
1,013,056
|
|
|
1,751,943
|
|
|
2.47
|
%
|
|||
|
Effective 2018
|
665,000
|
|
|
507,222
|
|
|
1,172,222
|
|
|
2.69
|
%
|
|||
|
Effective 2019
|
338,223
|
|
|
224,890
|
|
|
563,113
|
|
|
2.99
|
%
|
|||
|
Effective 2020
|
266,277
|
|
|
158,860
|
|
|
425,137
|
|
|
3.10
|
%
|
|||
|
Effective 2021
|
191,319
|
|
|
—
|
|
|
191,319
|
|
|
2.13
|
%
|
|||
|
Effective 2022
|
180,000
|
|
|
—
|
|
|
180,000
|
|
|
2.13
|
%
|
|||
|
Effective 2023
|
159,478
|
|
|
—
|
|
|
159,478
|
|
|
2.15
|
%
|
|||
|
Effective 2024
|
38,874
|
|
|
—
|
|
|
38,874
|
|
|
2.18
|
%
|
|||
|
|
Three Months Ended
|
||
|
($ in thousands)
|
March 31, 2014
|
||
|
Agency:
|
|
||
|
RMBS
|
$
|
14,908
|
|
|
CMBS
|
982
|
|
|
|
CMBS IO
|
3,160
|
|
|
|
Non-Agency:
|
|
||
|
RMBS
|
(135
|
)
|
|
|
CMBS
|
6,751
|
|
|
|
CMBS IO
|
1,606
|
|
|
|
Total change in fair value of MBS investments, net of net losses on sales of investments realized in net income
|
27,272
|
|
|
|
Reclassification adjustment for amortization of de-designated cash flow hedges
|
2,288
|
|
|
|
Increase in AOCI
|
$
|
29,560
|
|
|
|
As of March 31, 2014
|
|||||||||||||
|
($ in thousands)
|
Asset Carrying Basis
|
|
Associated Financing
(1)
/ Liability Carrying Basis
|
|
Allocated Shareholders’ Equity
|
|
% of Shareholders’ Equity
|
|||||||
|
Agency MBS
|
$
|
3,356,759
|
|
|
$
|
2,998,479
|
|
|
$
|
358,280
|
|
|
59.8
|
%
|
|
Non-Agency MBS
|
603,093
|
|
|
486,459
|
|
|
116,634
|
|
|
19.5
|
%
|
|||
|
Mortgage loans held for investment, net
|
53,804
|
|
|
29,086
|
|
|
24,718
|
|
|
4.1
|
%
|
|||
|
Derivative assets (liabilities)
|
12,064
|
|
|
11,137
|
|
|
927
|
|
|
0.2
|
%
|
|||
|
Cash and cash equivalents
|
61,168
|
|
|
—
|
|
|
61,168
|
|
|
10.2
|
%
|
|||
|
Restricted cash
|
18,242
|
|
|
—
|
|
|
18,242
|
|
|
3.0
|
%
|
|||
|
Other assets/other liabilities
|
39,152
|
|
|
20,106
|
|
|
19,046
|
|
|
3.2
|
%
|
|||
|
|
$
|
4,144,282
|
|
|
$
|
3,545,267
|
|
|
$
|
599,015
|
|
|
100.0
|
%
|
|
|
As of December 31, 2013
|
|||||||||||||
|
($ in thousands)
|
Asset Carrying Basis
|
|
Associated Financing
(1)
/ Liability Carrying Basis
|
|
Allocated Shareholders’ Equity
|
|
% of Shareholders’ Equity
|
|||||||
|
Agency MBS
|
$
|
3,483,978
|
|
|
$
|
3,149,470
|
|
|
$
|
334,508
|
|
|
57.1
|
%
|
|
Non-Agency MBS
|
534,183
|
|
|
420,991
|
|
|
113,192
|
|
|
19.3
|
%
|
|||
|
Mortgage loans held for investment, net
|
55,423
|
|
|
33,565
|
|
|
21,858
|
|
|
3.7
|
%
|
|||
|
Derivative assets (liabilities)
|
18,488
|
|
|
6,681
|
|
|
11,807
|
|
|
2.0
|
%
|
|||
|
Restricted cash
|
69,330
|
|
|
—
|
|
|
69,330
|
|
|
11.8
|
%
|
|||
|
Cash and cash equivalents
|
13,385
|
|
|
—
|
|
|
13,385
|
|
|
2.4
|
%
|
|||
|
Other assets/other liabilities
|
42,350
|
|
|
20,554
|
|
|
21,796
|
|
|
3.7
|
%
|
|||
|
|
$
|
4,217,137
|
|
|
$
|
3,631,261
|
|
|
$
|
585,876
|
|
|
100.0
|
%
|
|
(1)
|
Associated financing related to investments includes repurchase agreements as well as payables pending for unsettled trades, if any, as of the date indicated, and non-recourse collateralized financing. Associated financing for derivative instruments represents the fair value of the derivative instruments in a liability position.
|
|
|
As of March 31, 2014
|
|||||||||||||
|
($ in thousands)
|
Asset Carrying Basis
|
|
Associated Financing
|
|
Invested Capital Allocation
|
|
% of Allocated Invested Capital
|
|||||||
|
RMBS and loans
|
$
|
2,588,739
|
|
|
$
|
2,386,707
|
|
|
$
|
202,032
|
|
|
40.4
|
%
|
|
CMBS and loans
|
742,145
|
|
|
579,938
|
|
|
162,207
|
|
|
32.5
|
%
|
|||
|
CMBS IO
|
682,772
|
|
|
547,379
|
|
|
135,393
|
|
|
27.1
|
%
|
|||
|
|
$
|
4,013,656
|
|
|
$
|
3,514,024
|
|
|
$
|
499,632
|
|
|
100.0
|
%
|
|
|
As of December 31, 2013
|
|||||||||||||
|
($ in thousands)
|
Asset Carrying Basis
|
|
Associated Financing
|
|
Invested Capital Allocation
|
|
% of Allocated Invested Capital
|
|||||||
|
RMBS and loans
|
$
|
2,741,124
|
|
|
$
|
2,558,395
|
|
|
$
|
182,729
|
|
|
38.9
|
%
|
|
CMBS and loans
|
720,996
|
|
|
569,123
|
|
|
151,873
|
|
|
32.4
|
%
|
|||
|
CMBS IO
|
611,464
|
|
|
476,508
|
|
|
134,956
|
|
|
28.7
|
%
|
|||
|
|
$
|
4,073,584
|
|
|
$
|
3,604,026
|
|
|
$
|
469,558
|
|
|
100.0
|
%
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
($ in thousands, except per share amounts)
|
2014
|
|
2013
|
||||
|
GAAP net (loss) income to common shareholders
|
$
|
(3,028
|
)
|
|
$
|
18,381
|
|
|
Amortization of de-designated cash flow hedges
(1)
|
2,288
|
|
|
—
|
|
||
|
Change in fair value on derivative instruments, net
(2)
|
11,211
|
|
|
(157
|
)
|
||
|
Loss (gain) on sale of investments, net
|
3,307
|
|
|
(1,391
|
)
|
||
|
Fair value adjustments, net
|
(32
|
)
|
|
140
|
|
||
|
Core net operating income to common shareholders
|
$
|
13,746
|
|
|
$
|
16,973
|
|
|
|
|
|
|
||||
|
Core net operating income to common shareholders per share
|
$
|
0.25
|
|
|
$
|
0.31
|
|
|
|
Three Months Ended
|
||||||||||||||||||||
|
|
March 31,
|
||||||||||||||||||||
|
|
2014
|
|
2013
|
||||||||||||||||||
|
($ in thousands)
|
Interest Income
|
|
Average
Balance
(1)
|
|
Effective Yield
(2)
|
|
Interest Income
|
|
Average
Balance
(1)
|
|
Effective Yield
(2)
|
||||||||||
|
Agency RMBS
|
$
|
11,895
|
|
|
$
|
2,636,227
|
|
|
1.84
|
%
|
|
$
|
13,417
|
|
|
$
|
2,564,732
|
|
|
2.04
|
%
|
|
Agency CMBS
|
2,870
|
|
|
318,023
|
|
|
3.52
|
%
|
|
3,033
|
|
|
331,780
|
|
|
3.60
|
%
|
||||
|
Agency CMBS IO
|
4,828
|
|
|
452,099
|
|
|
4.25
|
%
|
|
7,718
|
|
|
560,329
|
|
|
4.59
|
%
|
||||
|
Total Agency
|
19,593
|
|
|
3,406,349
|
|
|
2.32
|
%
|
|
24,168
|
|
|
3,456,841
|
|
|
2.60
|
%
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Non-Agency RMBS
|
508
|
|
|
15,588
|
|
|
6.64
|
%
|
|
$
|
140
|
|
|
$
|
10,024
|
|
|
5.61
|
%
|
||
|
Non-Agency CMBS
|
5,043
|
|
|
361,391
|
|
|
5.56
|
%
|
|
6,466
|
|
|
455,334
|
|
|
5.55
|
%
|
||||
|
Non-Agency CMBS IO
|
1,758
|
|
|
162,957
|
|
|
4.12
|
%
|
|
1,265
|
|
|
106,954
|
|
|
4.68
|
%
|
||||
|
Total Non-Agency
|
7,309
|
|
|
539,936
|
|
|
5.16
|
%
|
|
7,871
|
|
|
572,312
|
|
|
5.39
|
%
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Total MBS portfolio
|
$
|
26,902
|
|
|
$
|
3,946,285
|
|
|
2.71
|
%
|
|
$
|
32,039
|
|
|
$
|
4,029,153
|
|
|
3.00
|
%
|
|
|
|
|
Due to Change in
|
||||||||
|
($ in thousands)
|
Increase (Decrease)
|
|
Average Balance
|
|
Average Yield
|
||||||
|
Agency MBS
|
$
|
(4,575
|
)
|
|
$
|
(326
|
)
|
|
$
|
(4,249
|
)
|
|
Non-Agency MBS
|
(562
|
)
|
|
(434
|
)
|
|
(128
|
)
|
|||
|
Total
|
$
|
(5,137
|
)
|
|
$
|
(760
|
)
|
|
$
|
(4,377
|
)
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
($ in thousands)
|
2014
|
|
2013
|
||||
|
Agency MBS:
|
|
|
|
||||
|
Gross interest
|
$
|
45,921
|
|
|
$
|
52,016
|
|
|
Net premium amortization
|
(26,328
|
)
|
|
(27,848
|
)
|
||
|
Total interest income
|
$
|
19,593
|
|
|
$
|
24,168
|
|
|
Average balance of unamortized premium, net
|
$
|
618,144
|
|
|
$
|
723,881
|
|
|
|
|
|
|
||||
|
Non-Agency MBS:
|
|
|
|
||||
|
Gross interest
|
$
|
13,277
|
|
|
$
|
11,607
|
|
|
Net premium amortization
|
(5,968
|
)
|
|
(3,736
|
)
|
||
|
Total interest income
|
$
|
7,309
|
|
|
$
|
7,871
|
|
|
Average balance of unamortized premium, net
|
$
|
144,470
|
|
|
$
|
89,063
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
($ in thousands)
|
2014
|
|
2013
|
||||
|
Repurchase agreements
|
$
|
5,323
|
|
|
$
|
6,115
|
|
|
Interest rate swap expense from cash flow hedging
|
—
|
|
|
4,103
|
|
||
|
Amortization of de-designated cash flow hedges
(1)
|
2,288
|
|
|
—
|
|
||
|
Non-recourse collateralized financing and other expenses
|
22
|
|
|
238
|
|
||
|
Total interest expense
|
$
|
7,633
|
|
|
$
|
10,456
|
|
|
|
|
|
|
||||
|
Average balance of repurchase agreements
|
$
|
3,497,167
|
|
|
$
|
3,612,319
|
|
|
Average balance of non-recourse collateralized financing
|
12,722
|
|
|
29,335
|
|
||
|
Average balance of borrowings
|
$
|
3,509,889
|
|
|
$
|
3,641,654
|
|
|
Annualized cost of funds
(2)
|
0.87
|
%
|
|
1.15
|
%
|
||
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
($ in thousands)
|
2014
|
|
2013
|
||||
|
Included in "interest expense" (from cash flow hedging)
|
$
|
—
|
|
|
$
|
4,103
|
|
|
Included in "loss on derivative instruments, net"
|
2,211
|
|
|
174
|
|
||
|
Total net periodic interest costs of derivative instruments:
|
$
|
2,211
|
|
|
$
|
4,277
|
|
|
|
Three Months
|
||||||||||||
|
|
March 31,
|
||||||||||||
|
|
2014
|
|
2013
|
||||||||||
|
($ in thousands)
|
Amount
|
|
Rate
(4)
|
|
Amount
|
|
Rate
(4)
|
||||||
|
GAAP interest expense/annualized cost of funds
|
$
|
7,633
|
|
|
0.87
|
%
|
|
$
|
10,456
|
|
|
1.15
|
%
|
|
Amortization of de-designated cash flow hedges
(1)
|
(2,288
|
)
|
|
(0.26
|
)%
|
|
—
|
|
|
—
|
%
|
||
|
Net periodic interest costs from derivative instruments
(2)
|
2,211
|
|
|
0.25
|
%
|
|
174
|
|
|
0.02
|
%
|
||
|
Effective borrowing costs/rate
|
$
|
7,556
|
|
|
0.86
|
%
|
|
$
|
10,630
|
|
|
1.17
|
%
|
|
|
|
|
|
|
|
|
|
||||||
|
Average balance of borrowings
(3)
|
$
|
3,509,889
|
|
|
|
|
|
$
|
3,641,654
|
|
|
|
|
|
|
Three Months Ended
|
||||||||||||
|
|
March 31,
|
||||||||||||
|
|
2014
|
|
2013
|
||||||||||
|
($ in thousands)
|
Amount
|
|
Yield
|
|
Amount
|
|
Yield
|
||||||
|
GAAP interest income
|
$
|
27,640
|
|
|
2.74
|
%
|
|
$
|
32,982
|
|
|
3.04
|
%
|
|
GAAP interest expense
|
7,633
|
|
|
0.87
|
%
|
|
10,456
|
|
|
1.15
|
%
|
||
|
Net interest income/spread
|
20,007
|
|
|
1.87
|
%
|
|
22,526
|
|
|
1.89
|
%
|
||
|
Amortization of de-designated cash flow hedges
(1)
|
2,288
|
|
|
0.26
|
%
|
|
—
|
|
|
—
|
%
|
||
|
Net periodic interest costs of derivative instruments
(2)
|
(2,211
|
)
|
|
(0.25
|
)%
|
|
(174
|
)
|
|
(0.02
|
)%
|
||
|
Adjusted net interest income/spread
|
$
|
20,084
|
|
|
1.88
|
%
|
|
$
|
22,352
|
|
|
1.87
|
%
|
|
|
|
|
|
|
|
|
|
||||||
|
Average interest earning assets
(3)
|
$
|
4,002,555
|
|
|
|
|
$
|
4,098,681
|
|
|
|
||
|
Average balance of borrowings
(4)
|
$
|
3,509,889
|
|
|
|
|
$
|
3,641,654
|
|
|
|
||
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
($ in thousands)
|
2014
|
|
2013
|
||||
|
Net periodic interest costs of derivative instruments
(1)
|
$
|
(2,211
|
)
|
|
$
|
(174
|
)
|
|
Change in fair value of derivative instruments, net
|
(11,211
|
)
|
|
157
|
|
||
|
Loss on derivative instruments, net
|
$
|
(13,422
|
)
|
|
$
|
(17
|
)
|
|
|
Three Months Ended
|
||||||||||||||
|
|
March 31,
|
||||||||||||||
|
|
2014
|
|
2013
|
||||||||||||
|
($ in thousands)
|
Amortized cost basis sold
|
|
Gain (loss) on sale of investments, net
|
|
Amortized cost basis sold
|
|
Gain (loss) on sale of investments, net
|
||||||||
|
Type of Investment
|
|
|
|
|
|
|
|
||||||||
|
Agency RMBS
|
$
|
56,801
|
|
|
$
|
(3,526
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Agency CMBS
|
—
|
|
|
—
|
|
|
1,960
|
|
|
(8
|
)
|
||||
|
Agency CMBS IO
|
326
|
|
|
19
|
|
|
18,233
|
|
|
353
|
|
||||
|
Non-Agency CMBS
|
5,978
|
|
|
200
|
|
|
9,573
|
|
|
1,046
|
|
||||
|
|
$
|
63,105
|
|
|
$
|
(3,307
|
)
|
|
$
|
29,766
|
|
|
$
|
1,391
|
|
|
(amounts in thousands)
|
Balance Outstanding As of Period End
|
|
Average Balance Outstanding For the Quarter Ended
|
|
Maximum Balance Outstanding During the Quarter Ended
|
||||||
|
March 31, 2014
|
$
|
3,485,544
|
|
|
$
|
3,497,167
|
|
|
$
|
3,580,997
|
|
|
December 31, 2013
|
3,580,754
|
|
|
3,603,477
|
|
|
3,675,290
|
|
|||
|
September 30, 2013
|
3,674,850
|
|
|
3,836,249
|
|
|
4,071,773
|
|
|||
|
June 30, 2013
|
4,071,392
|
|
|
4,042,340
|
|
|
4,255,294
|
|
|||
|
March 31, 2013
|
3,708,255
|
|
|
3,612,319
|
|
|
3,752,000
|
|
|||
|
(amounts in thousands)
|
Amount Outstanding
|
|
Market Value of Collateral Pledged
|
||||
|
North America
|
$
|
2,115,669
|
|
|
$
|
2,350,820
|
|
|
Asia
|
854,608
|
|
|
899,558
|
|
||
|
Europe
|
515,406
|
|
|
563,977
|
|
||
|
|
$
|
3,485,683
|
|
|
$
|
3,814,355
|
|
|
|
March 31, 2014
|
|
December 31, 2013
|
|
September 30, 2013
|
|
June 30, 2013
|
|
March 31, 2013
|
|||||
|
Agency MBS
|
6.9
|
%
|
|
6.8
|
%
|
|
6.7
|
%
|
|
6.6
|
%
|
|
7.3
|
%
|
|
Non-Agency MBS
|
19.8
|
%
|
|
20.1
|
%
|
|
20.0
|
%
|
|
19.7
|
%
|
|
19.1
|
%
|
|
|
March 31, 2014
|
||||||
|
(amounts in thousands)
|
Amount Outstanding
|
|
Equity at risk
|
||||
|
Well Fargo Bank, N.A. and affiliates
(1)
|
$
|
348,399
|
|
|
$
|
97,517
|
|
|
JP Morgan Securities, LLC
|
274,519
|
|
|
43,858
|
|
||
|
South Street Financial Corporation
|
603,608
|
|
|
28,342
|
|
||
|
Credit Suisse Securities LLC
|
198,749
|
|
|
25,534
|
|
||
|
Bank of America Securities LLC
|
208,359
|
|
|
22,556
|
|
||
|
Remaining counterparties
|
1,852,049
|
|
|
110,865
|
|
||
|
|
$
|
3,485,683
|
|
|
$
|
328,672
|
|
|
|
December 31, 2013
|
||||||
|
(amounts in thousands)
|
Amount Outstanding
|
|
Equity at risk
|
||||
|
Well Fargo Bank, N.A. and affiliates
(1)
|
$
|
371,753
|
|
|
$
|
91,769
|
|
|
JP Morgan Securities, LLC
|
240,024
|
|
|
39,397
|
|
||
|
South Street Financial Corporation
|
601,354
|
|
|
29,331
|
|
||
|
Credit Suisse Securities LLC
|
210,861
|
|
|
25,093
|
|
||
|
Bank of America Securities LLC
|
226,768
|
|
|
23,886
|
|
||
|
Remaining counterparties
|
1,930,237
|
|
|
102,797
|
|
||
|
|
$
|
3,580,997
|
|
|
$
|
312,273
|
|
|
(amounts in thousands)
|
Payments due by period
|
||||||||||||||||||
|
Contractual Obligations:
(1) (2)
|
Total
|
|
< 1 year
|
|
1-3 years
|
|
3-5 years
|
|
> 5 years
|
||||||||||
|
Securitization financing
(3)
|
$
|
12,607
|
|
|
$
|
3,571
|
|
|
$
|
4,403
|
|
|
$
|
4,633
|
|
|
$
|
—
|
|
|
Operating lease obligations
|
1,085
|
|
|
119
|
|
|
200
|
|
|
206
|
|
|
560
|
|
|||||
|
Total
|
$
|
13,692
|
|
|
$
|
3,690
|
|
|
$
|
4,603
|
|
|
$
|
4,839
|
|
|
$
|
560
|
|
|
•
|
Our business and investment strategy including our ability to generate acceptable risk-adjusted returns and our target investment allocations;
|
|
•
|
Monetary policy of the Federal Reserve;
|
|
•
|
Our financing and hedging strategy, including our target leverage ratios, anticipated trends in financing costs, changes to the derivative instruments to which we are a party, and changes to government regulation of hedging instruments and our use of these instruments;
|
|
•
|
Our investment portfolio composition and target investments;
|
|
•
|
Our investment portfolio performance, including the fair value, yields, and forecasted prepayment speeds of our investment portfolio;
|
|
•
|
Our liquidity and ability to access financing, and the anticipated availability and cost of financing;
|
|
•
|
Our use of and restrictions on using our tax NOL carryfoward;
|
|
•
|
The status of pending litigation;
|
|
•
|
Estimates of future interest expenses related to the Company's derivative instruments;
|
|
•
|
The status of regulatory rule-making or review processes and the status of reform efforts in the repurchase agreement financing market;
|
|
•
|
Market, industry and economic trends; and
|
|
•
|
Interest rates.
|
|
•
|
the risks and uncertainties referenced in this Quarterly Report on Form 10-Q, particularly those set forth under Part II, Item 1A, “Risk Factors”;
|
|
•
|
our ability to find suitable reinvestment opportunities;
|
|
•
|
changes in economic conditions;
|
|
•
|
changes in interest rates and interest rate spreads, including the repricing of interest-earning assets and interest-bearing liabilities;
|
|
•
|
our investment portfolio performance particularly as it relates to cash flow, prepayment rates and credit performance;
|
|
•
|
actual or anticipated changes in Federal Reserve monetary policy;
|
|
•
|
adverse reactions in financial markets related to the budget deficit or national debt of the United States government; potential or actual default by the United States government on Treasury securities; and potential or actual downgrades to the sovereign credit rating of the United States;
|
|
•
|
the cost and availability of financing, including the future availability of financing due to changes to regulation of, and capital requirements imposed upon, financial institutions;
|
|
•
|
the cost and availability of new equity capital;
|
|
•
|
changes in our use of leverage;
|
|
•
|
the quality of performance of third-party servicer providers of our loans and loans underlying our securities;
|
|
•
|
the level of defaults by borrowers on loans we have securitized;
|
|
•
|
changes in our industry;
|
|
•
|
increased competition;
|
|
•
|
changes in government regulations affecting our business;
|
|
•
|
changes in the repurchase agreement financing markets and other credit markets;
|
|
•
|
changes to the market for interest rate swaps and other derivative instruments, including changes to margin requirements on derivative instruments;
|
|
•
|
government initiatives to support the U.S financial system and U.S. housing and real estate markets; or to reform the U.S. housing finance system including by imposing standards for originating residential mortgage loans;
|
|
•
|
GSE reform or other government policies and actions; and
|
|
•
|
ownership shifts under Section 382 that further limit the use of our tax NOL carryforward.
|
|
•
|
The "percentage change in adjusted net interest income" included in the table below includes the anticipated impact of changes in expected prepayment speeds on our investments and also assumes that net proceeds received from pay downs on the portfolio are reinvested in MBS in amounts proportionate to the portfolio composition that existed as of
March 31, 2014
and at yields consistent with those as of
March 31, 2014
adjusted for the parallel shift in the rates below.
|
|
•
|
The "percentage change in market value" included in the table below is based on the immediate change in market value of the investment portfolio based on the instantaneous shift in market interest rates. The projections for market value do not assume any change in credit spreads.
|
|
Parallel Shift in Interest Rates
|
|
Percentage change in adjusted net interest income
(1)
|
|
Percentage change in market value
(2)
|
|
+100
|
|
(12.5)%
|
|
(1.5)%
|
|
+50
|
|
(1.6)%
|
|
(0.7)%
|
|
0
|
|
—%
|
|
—%
|
|
-50
|
|
8.0%
|
|
0.5%
|
|
(1)
|
Includes changes in interest expense from the financings for our investments as well as our derivative instruments.
|
|
(2)
|
Includes changes in market value of our investments and derivative instruments, but excludes changes in market value of our financings because they are not carried at fair value on our balance sheet.
|
|
Basis point change in
2-year yield
|
|
Basis point change in
10-year yield
|
|
Percentage change in
projected market value
|
|
0
|
|
+25
|
|
(0.1)%
|
|
+10
|
|
+50
|
|
(0.3)%
|
|
+10
|
|
+75
|
|
(0.5)%
|
|
+25
|
|
+75
|
|
(0.6)%
|
|
+25
|
|
0
|
|
(0.2)%
|
|
+50
|
|
0
|
|
(0.4)%
|
|
-10
|
|
-50
|
|
0.2%
|
|
Lifetime Interest Rate Caps
|
|
Interim Interest Rate Caps
|
||||
|
|
% of Total
|
|
|
% of Total
|
||
|
>7.0% to 10.0%
|
87.1
|
%
|
|
1.0%
|
0.1
|
%
|
|
>10.0% to 11.0%
|
9.7
|
%
|
|
2.0%
|
16.3
|
%
|
|
>11.0% to 12.1%
|
3.2
|
%
|
|
5.0%
|
83.6
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
Basis Point Change in Market Credit Spreads
|
|
Percentage change in projected market value
|
|
+50
|
|
(2.1)%
|
|
+25
|
|
(1.1)%
|
|
0
|
|
—%
|
|
-25
|
|
1.1%
|
|
-50
|
|
2.2%
|
|
|
March 31, 2014
|
|
December 31, 2013
|
|
September 30, 2013
|
|
June 30, 2013
|
||||||||||||||||||||
|
($ in thousands)
|
Net Premium
|
|
WAC
|
|
Net Premium
|
|
WAC
|
|
Net Premium
|
|
WAC
|
|
Net Premium
|
|
WAC
|
||||||||||||
|
0-12 MTR
|
$
|
37,353
|
|
|
3.02
|
%
|
|
$
|
42,082
|
|
|
2.97
|
%
|
|
$
|
35,943
|
|
|
2.91
|
%
|
|
$
|
35,673
|
|
|
3.29
|
%
|
|
13-24 MTR
|
9,210
|
|
|
3.64
|
%
|
|
11,234
|
|
|
3.73
|
%
|
|
19,583
|
|
|
3.80
|
%
|
|
23,270
|
|
|
3.81
|
%
|
||||
|
25-60 MTR
|
46,756
|
|
|
3.50
|
%
|
|
46,419
|
|
|
3.66
|
%
|
|
6,894
|
|
|
3.66
|
%
|
|
7,109
|
|
|
3.76
|
%
|
||||
|
> 60 MTR
|
46,591
|
|
|
3.00
|
%
|
|
54,496
|
|
|
2.99
|
%
|
|
99,961
|
|
|
3.00
|
%
|
|
104,185
|
|
|
3.05
|
%
|
||||
|
Fixed rate
|
(11
|
)
|
|
2.51
|
%
|
|
(11
|
)
|
|
2.51
|
%
|
|
(11
|
)
|
|
2.51
|
%
|
|
(12
|
)
|
|
2.51
|
%
|
||||
|
Total premium, net
|
$
|
139,899
|
|
|
3.20
|
%
|
|
$
|
154,220
|
|
|
3.22
|
%
|
|
$
|
162,370
|
|
|
3.26
|
%
|
|
$
|
170,225
|
|
|
3.34
|
%
|
|
Par/notional balance
|
$2,438,133
|
|
|
|
$2,591,568
|
|
|
|
$2,723,084
|
|
|
|
$2,966,661
|
|
|
||||||||||||
|
Premium, net as a % of par value
|
5.7
|
%
|
|
|
|
6.0
|
%
|
|
|
|
6.0
|
%
|
|
|
|
5.7
|
%
|
|
|
||||||||
|
(amounts in thousands)
|
March 31, 2014
|
|
December 31, 2013
|
|
September 30, 2013
|
|
June 30, 2013
|
||||||||
|
Fannie Mae
|
$
|
68,587
|
|
|
$
|
70,288
|
|
|
$
|
73,214
|
|
|
$
|
78,630
|
|
|
Freddie Mac
|
325,447
|
|
|
312,089
|
|
|
309,147
|
|
|
311,496
|
|
||||
|
Ginnie Mae
|
77,211
|
|
|
77,950
|
|
|
93,247
|
|
|
160,063
|
|
||||
|
|
$
|
471,245
|
|
|
$
|
460,327
|
|
|
$
|
475,608
|
|
|
$
|
550,189
|
|
|
|
March 31, 2014
|
|||||||||||||
|
(amounts in thousands)
|
CMBS
|
|
CMBS IOs
|
|
RMBS
|
|
Weighted average
|
|||||||
|
AAA
|
$
|
—
|
|
|
$
|
210,184
|
|
|
$
|
—
|
|
|
34.9
|
%
|
|
AA
|
75,990
|
|
|
1,343
|
|
|
—
|
|
|
12.8
|
%
|
|||
|
A
(1)
|
251,959
|
|
|
—
|
|
|
—
|
|
|
41.8
|
%
|
|||
|
Below A or not rated
(1)
|
48,047
|
|
|
—
|
|
|
15,570
|
|
|
10.5
|
%
|
|||
|
|
$
|
375,996
|
|
|
$
|
211,527
|
|
|
$
|
15,570
|
|
|
100.0
|
%
|
|
ITEM 4.
|
CONTROLS AND PROCEDURES
|
|
ITEM 1.
|
LEGAL PROCEEDINGS
|
|
|
Total Number of Shares Purchased
(1)
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs
|
||||||
|
|
|
|
|
|
|
|
($ in thousands)
|
||||||
|
January 1, 2014 - January 31, 2014
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
42,145
|
|
|
February 1, 2014 - February 28, 2014
|
23,864
|
|
|
8.14
|
|
|
—
|
|
|
42,145
|
|
||
|
March 1 - March 31, 2014
|
35,286
|
|
|
8.81
|
|
|
—
|
|
|
42,145
|
|
||
|
Total
|
59,150
|
|
|
$
|
8.54
|
|
|
—
|
|
|
$
|
42,145
|
|
|
Exhibit No.
|
Description
|
|
3.1
|
Restated Articles of Incorporation, effective July 9, 2008 (incorporated herein by reference to Exhibit 3.1 to Dynex’s Current Report on Form 8-K filed July 11, 2008).
|
|
3.1.1
|
Articles of Amendment to the Restated Articles of Incorporation, effective July 30, 2012 (incorporated herein by reference to Exhibit 3.1.1 to Dynex's Registration Statement on Form 8-A filed August 1, 2012).
|
|
3.1.2
|
Articles of Amendment to the Restated Articles of Incorporation, effective April 15, 2013 (incorporated herein by reference to Exhibit 3.1 to Dynex’s Current Report on Form 8-K filed April 16, 2013).
|
|
3.1.3
|
Articles of Amendment to the Restated Articles of Incorporation, effective June 11, 2013 (incorporated herein by reference to Exhibit 3.1.3 to Dynex's Quarterly Report on Form 10-Q filed August 9, 2013).
|
|
3.2
|
Amended and Restated Bylaws, amended as of December 12, 2013 (incorporated herein by reference to Exhibit 3.2 to Dynex's Annual Report on Form 10-K filed March 4, 2014).
|
|
10.17
|
Base salaries for executive officers of Dynex Capital, Inc. (Corrected) (filed herewith)
|
|
31.1
|
Certification of principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
|
|
31.2
|
Certification of principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
|
|
32.1
|
Certification of principal executive officer and principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
|
|
101
|
The following materials from Dynex Capital, Inc.'s Quarterly Report on Form 10-Q for the three months ended March 31, 2014, formatted in XBRL (Extensible Business Reporting Language), filed herewith: (i) Consolidated Balance Sheets (unaudited), (ii) Consolidated Statements of Comprehensive Income (unaudited), (iii) Consolidated Statements of Shareholders' Equity (unaudited), (iv) Consolidated Statements of Cash Flows (unaudited), and (v) Notes to the Unaudited Consolidated Financial Statements.
|
|
|
|
DYNEX CAPITAL, INC.
|
|
|
|
|
|
|
|
|
|
Date:
|
May 12, 2014
|
/s/ Byron L. Boston
|
|
|
|
Byron L. Boston
|
|
|
|
Chief Executive Officer, President,
|
|
|
|
Co-Chief Investment Officer, and Director
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
Date:
|
May 12, 2014
|
/s/ Stephen J. Benedetti
|
|
|
|
Stephen J. Benedetti
|
|
|
|
Executive Vice President, Chief Operating Officer and Chief Financial Officer
|
|
|
|
(Principal Financial Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|